Progress towards gene therapy for cystic fibrosis

@article{Tate2005ProgressTG,
  title={Progress towards gene therapy for cystic fibrosis},
  author={Stephen Tate and Stuart Elborn},
  journal={Expert Opinion on Drug Delivery},
  year={2005},
  volume={2},
  pages={269 - 280}
}
  • S. Tate, S. Elborn
  • Published 1 March 2005
  • Biology, Medicine
  • Expert Opinion on Drug Delivery
A decade ago it was widely anticipated that cystic fibrosis would be one of the first diseases to be treated by gene therapy. The difficult hurdle of cloning the responsible gene had been accomplished, its function was established and the lung appeared readily accessible for gene replacement. Since the first clinical trials for cystic fibrosis lung disease in the early 1990s it has become increasingly apparent that successful lung-directed gene therapy is significantly more complex than was… 
Gene and cell therapy for cystic fibrosis: from bench to bedside.
TLDR
New viral and nonviral gene therapy vectors, as well as human artificial chromosomes, are reviewed to overcome barriers to successful CFTR expression and the therapeutic potential of stem cells for CF lung disease is discussed.
α-Fetoprotein gene delivery to the nasal epithelium of nonhuman primates by human parainfluenza viral vectors.
TLDR
It is demonstrated that PIV mediates efficient gene transfer in rhesus epithelium as in the human counterpart, and PIV vectors appear to be promising airway-specific gene transfer vehicles that warrant further development.
Cystic Fibrosis - An Update
TLDR
Although CF is a rare disease in Bangladesh, the prognosis has improved due to earlier diagnosis through screening, better treatment and access to health care, and its possibility should be kept in mind in appropriate circumstances.
Targeting the Root Cause of Cystic Fibrosis.
TLDR
The current status in CF-cause targeting therapy is summarized and recent development in CF therapy suggests a brighter future for CF patients.
Impact of deletion of envelope-related genes of recombinant Sendai viruses on immune responses following pulmonary gene transfer of neonatal mice
TLDR
The results indicate that pulmonary gene transfer using SeV/dFdMdHN warrants further investigation for its possible use in developing safer therapeutics for neonatal lung diseases, including cystic fibrosis.
Efficient intratracheal delivery of airway epithelial cells in mice and pigs.
TLDR
The results have demonstrated the convenience and efficiency of direct delivery of exogenous epithelial cells to lungs in mouse and pig models and provided important background for future preclinical evaluation of intratracheal cell transplantation to treat lung diseases.
IMMOBILIZED COBALT AFFINITY PURIFICATION FOR HSV-1 BASED GENE THERAPY VECTORS
Herpes simplex virus type 1 (HSV-1) is a promising vector for gene therapy applications. To be used as therapeutic agents, HSV-1 vectors must meet the stringent criteria of high titer and purity.
Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension
TLDR
Light is shed on P2Y receptors and more is focused on the P2y2 receptor as a potential novel player in PAH and as a new therapeutic target for disease management.
Mechanism of retroviral genomic RNA dimerization and packaging
TLDR
A framework for assembly of the retroviral RNA dimer is developed, and the monomer and dimer MiDAS structures for two murine retroviruses, while not identical, are similarly organized.
Passive permeability and effective pore size of HeLa cell nuclear membranes
TLDR
This work uses fluorescein isothiocyanate‐labeled dextran molecules as a model system and studies the passive nuclear import of biomolecules through nuclear pore complexes in digitonin‐permeabilized HeLa cells.
...
1
2
...

References

SHOWING 1-10 OF 104 REFERENCES
Non-viral vectors in cystic fibrosis gene therapy: progress and challenges.
Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis
Inactivation of E2a in recombinant adenoviruses improves the prospect for gene therapy in cystic fibrosis
TLDR
It is shown that with first generation adenovirus–mediated gene transfer to the mouse lung, viral proteins are expressed leading to destructive cellular immune responses and repopulation of the lung with nontransgene containing cells.
Efficient gene transfer to airway epithelium using recombinant Sendai virus
TLDR
It is shown that recombinant Sendai virus (SeV) produces efficient transfection throughout the respiratory tract of both mice and ferrets in vivo, as well as in freshly obtained human nasal epithelial cells in vitro.
Targeting transgene expression for cystic fibrosis gene therapy.
  • D. Koehler, V. Hannam, +6 authors J. Hu
  • Biology, Medicine
    Molecular therapy : the journal of the American Society of Gene Therapy
  • 2001
TLDR
The data demonstrate that a KRT18-driven expression vector delivered systemically can target gene expression to CF-affected tissues, despite an uneven distribution of plasmid DNA.
Non-viral gene transfer therapy for cystic fibrosis
TLDR
Improvements in this and other non-viral methods are in process and include targeting the complexes to the desired cells using receptor ligands, lessening toxicity by changing the mix of lipids or adding protective molecules to polycations, and modifying the plasmid DNA to reduce inflammatory CpG sequences and enhance intensity, duration and tissue specificity of expression.
A CONTROLLED STUDY OF ADENOVIRAL-VECTOR – MEDIATED GENE TRANSFER IN THE NASAL EPITHELIUM OF PATIENTS WITH CYSTIC FIBROSIS
Background. Cystic fibrosis is a monogenic disease that deranges multiple systems of ion transport in the airways, culminating in chronic infection and destruction of the lung. The introduction of a
Progress toward generating a ferret model of cystic fibrosis by somatic cell nuclear transfer
TLDR
Over the past few years, the laboratory has investigated several experimental parameters required for gene targeting and nuclear transfer cloning in the ferret using somatic cells, and discussed the progress and the hurdles to NT cloning and gene-targeting that accompany efforts to generate animal models of genetic diseases in species such as the ferrets.
Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis
TLDR
The efficacy measures suggest that unlike high doses of recombinant adenoviral vectors, DNA/liposomes can be successfully re-administered without apparent loss of efficacy.
Safety of single-dose administration of an adeno-associated virus (AAV)-CFTR vector in the primate lung.
TLDR
Results indicate that transduction of the primate airway epithelium with the AAV-CFTR mediates long-term CFTR cDNA transfer and is relatively safe, which is an important step before its use in humans.
...
1
2
3
4
5
...